[1]

AIHW. National Bowel Cancer Screening Program: monitoring report 2018. AIHW; 2018.
[2]

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.

doi: 10.3322/caac.21492
[3]

Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013 Feb;62(3):367–86.

doi: 10.1111/his.12055
[4]

Terada T. Histopathologic study of the rectum in 1, 464 consecutive rectal specimens in a single Japanese hospital: Ⅱ. malignant lesions. Int J Clin Exp Pathol. 2013;6(3):385–94.
[5]

van Rossum LG, van Rijn AF, Verbeek AL, van Oijen MG, Laheij RJ, Fockens P, et al. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis. Int J Cancer. 2011 Apr;128(8):1908–17.

doi: 10.1002/ijc.25530
[6]

He X, Hang D, Wu K, Nayor J, Drew DA, Giovannucci EL, et al. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps. Gastroenterology. 2019 Jul;S0016-5085(19)41086-X.
[7]

Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019 Oct; 367:l5515.
[8]

Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, et al. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2019, Epub ahead of print.
[9]

Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr;370(14):1298–306.

doi: 10.1056/NEJMoa1309086
[10]

Chittleborough TJ, Kong JC, Guerra GR, Ramsay R, Heriot AG. Colonoscopic surveillance: quality, guidelines and effectiveness. ANZ J Surg. 2018 Jan;88(1-2):32–8.

doi: 10.1111/ans.14141
[11]

Laird-Fick HS, Chahal G, Olomu A, Gardiner J, Richard J, Dimitrov N. Colonic polyp histopathology and location in a community-based sample of older adults. BMC Gastroenterol. 2016 Aug;16(1):90.

doi: 10.1186/s12876-016-0497-1
[12]

Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017 Jan;66(1):97–106.

doi: 10.1136/gutjnl-2015-310456
[13]

Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, et al. Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps. Gastroenterology. 2016 Apr;150(4):895–902.e5.

doi: 10.1053/j.gastro.2015.11.046
[14]

Melson J, Ma K, Arshad S, Greenspan M, Kaminsky T, Melvani V, et al. Presence of small sessile serrated polyps increases rate of advanced neoplasia upon surveillance compared with isolated low-risk tubular adenomas. Gastrointest Endosc. 2016 Aug;84(2):307–14.

doi: 10.1016/j.gie.2016.01.064
[15]

Payne SR, Church TR, Wandell M, Rösch T, Osborn N, Snover D, et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol. 2014 Jul;12(7):1119–26.

doi: 10.1016/j.cgh.2013.11.034
[16]

Lee J, Park SW, Kim YS, Lee KJ, Sung H, Song PH, et al. Risk factors of missed colorectal lesions after colonoscopy. Medicine (Baltimore). 2017 Jul;96(27):e7468.

doi: 10.1097/MD.0000000000007468
[17]

Mandaliya R, Baig K, Barnhill M, Murugesan V, Som A, Mohammed U, et al. Significant Variation in the Detection Rates of Proximal Serrated Polyps Among Academic Gastroenterologists, Community Gastroenterologists, and Colorectal Surgeons in a Single Tertiary Care Center. Dig Dis Sci. 2019 Sep;64(9):2614–21.

doi: 10.1007/s10620-019-05664-w
[18]

Francis DL, Rodriguez-Correa DT, Buchner A, Harewood GC, Wallace M. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc. 2011 Mar;73(3):493–7.

doi: 10.1016/j.gie.2011.01.005
[19]

Patel NC, Islam RS, Wu Q, Gurudu SR, Ramirez FC, Crowell MD, et al. Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate. Gastrointest Endosc. 2013 Mar;77(3):390–4.

doi: 10.1016/j.gie.2012.09.032
[20]

Elhanafi S, Ortiz AM, Yarlagadda A, Tsai C, Eloliby M, Mallawaarachchi I, et al. Estimation of the Adenoma Detection Rate From the Polyp Detection Rate by Using a Conversion Factor in a Predominantly Hispanic Population. J Clin Gastroenterol. 2015 Aug;49(7):589–93.

doi: 10.1097/MCG.0000000000000179
[21]

Murchie B, Tandon K, Zackria S, Wexner SD, O’Rourke C, Castro FJ. Can polyp detection rate be used prospectively as a marker of adenoma detection rate? Surg Endosc. 2018 Mar;32(3):1141–8.

doi: 10.1007/s00464-017-5785-5
[22]

Cicchetti DV. Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. Psychol Assess. 1994;6(4):284–90.

doi: 10.1037/1040-3590.6.4.284
[23]

Hazewinkel Y, de Wijkerslooth TR, Stoop EM, Bossuyt PM, Biermann K, van de Vijver MJ, et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy. 2014 Mar;46(3):219–24.
[24]

Lee CK, Kim YW, Shim JJ, Jang JY. Prevalence of proximal serrated polyps and conventional adenomas in an asymptomatic average-risk screening population. Gut Liver. 2013 Sep;7(5):524–31.

doi: 10.5009/gnl.2013.7.5.524
[25]

Zhu H, Qin H, Huang Z, Li S, Zhu X, He J, et al. Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma. Int J Clin Exp Pathol. 2015 Aug;8(8):9351–9.
[26]

Gurudu SR, Heigh RI, De Petris G, Heigh EG, Leighton JA, Pasha SF, et al. Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol. 2010 Jul;16(27):3402–5.

doi: 10.3748/wjg.v16.i27.3402
[27]

Abdeljawad K, Vemulapalli KC, Kahi CJ, Cummings OW, Snover DC, Rex DK. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc. 2015 Mar;81(3):517–24.

doi: 10.1016/j.gie.2014.04.064
[28]

IJspeert JE, de Wit K, van der Vlugt M, Bastiaansen BA, Fockens P, Dekker E; JE IJ. Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy. 2016 Aug;48(8):740–6.

doi: 10.1055/s-0042-105436
[29]

Bettington M, Walker N, Rahman T, Vandeleur A, Whitehall V, Leggett B, et al. High prevalence of sessile serrated adenomas in contemporary outpatient colonoscopy practice. Intern Med J. 2017 Mar;47(3):318–23.

doi: 10.1111/imj.13329
[30]

Ohki D, Tsuji Y, Shinozaki T, Sakaguchi Y, Minatsuki C, Kinoshita H, et al. Sessile serrated adenoma detection rate is correlated with adenoma detection rate. World J Gastrointest Oncol. 2018 Mar;10(3):82–90.

doi: 10.4251/wjgo.v10.i3.82
[31]

Pyo JH, Ha SY, Hong SN, Chang DK, Son HJ, Kim KM, et al. Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis. J Gastroenterol Hepatol. 2018 May;33(5):1039–46.

doi: 10.1111/jgh.14035
[32]

Crockett SD, Nagtegaal ID. Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia. Gastroenterology. 2019 Oct;157(4):949–966.e4.

doi: 10.1053/j.gastro.2019.06.041